


The Fund aims to maximise long term total return.
| Name | % Net Assets |
|---|---|
| Dunedin Smaller Companies | 4.7% |
| British American Tobacco | 4.5% |
| Royal Dutch Shell 'B' | 3.8% |
| AstraZeneca | 3.6% |
| HSBC | 3.6% |
| Centrica | 3.5% |
| Aviva | 3.1% |
| Schroders | 3.1% |
| Associated British Foods | 3.0% |
| Tesco | 2.9% |
| Key | % Net Assets |
|---|---|
| 4.7% | |
| 4.5% | |
| 3.8% | |
| 3.6% | |
| 83.4% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | n/a |
|---|---|
| Fund Manager | Pan European Equities Team |
| TER | 2.13 (31-Jan-2009) |
| Minimum Investment | |
|---|---|
| Initial | 500 |
| Additional | 100 |
| Savings | 50 |
| Charges | |
|---|---|
| Initial | 4.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.13 |
You are here: research